Evelo Biosciences EVLO
$ 0.32
-14.46%
Quarterly report 2023-Q3
added 11-09-2023
Country |
USA |
IPO year |
2018 |
Industry |
Biotechnology |
Stock Exchange |
NASDAQ GLOBAL |
CEO |
Dr. Balkrishan Gill |
Employees in the company |
98 |
Shares |
87.2 M |
Market Cap[1] |
$ 27.9 M |
EBITDA (LTM) |
$ -83.2 M |
P/E (LTM) |
-0.03 |
P/S (LTM) |
- |
EPS (LTM) |
-10.38 |
Other stocks of industry "Biotechnology"
References
- Pavone, P. (2019). Market capitalization and financial variables: Evidence from Italian listed companies. International Journal of Academic Research Business and Social Sciences, 9(3), 1356-1371.